Acumen Pharmaceuticals, Inc. (ABOS) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $52.40M | -8.3% |
| 2024 | $57.18M | +32.5% |
| 2023 | $43.15M | +452.4% |
| 2022 | $7.81M | +51.8% |
| 2021 | $5.15M | -19.2% |
| 2020 | $6.37M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $52.40M | -8.3% |
| 2024 | $57.18M | +32.5% |
| 2023 | $43.15M | +452.4% |
| 2022 | $7.81M | +51.8% |
| 2021 | $5.15M | -19.2% |
| 2020 | $6.37M | — |